Stemming the tide

Andrzej KrauzeThe number of European researchers who leave Europe for greener pastures abroad has continued to make headlines on a regular basis in recent months. Time magazine, for example, reported in January that some 400,000 European science and technology graduates now live in the United States, and the European Commission says that only 13% of European science professionals working abroad intend to return home. More recent studies from Germany question whether the picture is as gloomy as t

| 3 min read

Register for free to listen to this article
Listen with Speechify
0:00
3:00
Share

Andrzej Krauze

The number of European researchers who leave Europe for greener pastures abroad has continued to make headlines on a regular basis in recent months. Time magazine, for example, reported in January that some 400,000 European science and technology graduates now live in the United States, and the European Commission says that only 13% of European science professionals working abroad intend to return home. More recent studies from Germany question whether the picture is as gloomy as these numbers suggest, but there's no question that legislators and funders of science in the European Union are spending a lot of time worrying about brain drain.

Considering this, it isn't surprising that some people in the United Kingdom are trying to get as much mileage as they can from the contrast between British and US policies on embryonic research and somatic cell nuclear replacement. In just four weeks between mid-May and ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies